Legend Biotech Corporation (NASDAQ:LEGN) Q3 2025 Earnings Call Transcript
Legend Biotech Corporation (NASDAQ:LEGN) Q3 2025 Earnings Call Transcript November 12, 2025Legend Biotech Corporation misses on earnings expectations.
Legend Biotech Corporation (LEGN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | IvyRock Asset Management Charles Huang | 856,900 | $27,943,509 | -2% | 12.01% |
| 2. | Renaissance Technologies Jim Simons | 843,200 | $27,496,752 | +29% | 0.04% |
| 3. | Hudson Bay Capital Management Sander Gerber | 220,000 | $7,174,200 | +43% | 0.02% |
| 4. | Triata Capital Sean Ho | 161,800 | $5,276,298 | +51% | 0.62% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 17,872 | $582,806 | +31% | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,094,486 | $198,741,180 | 0.83% | |
| 2. | 4,494,623 | $146,569,648 | 0% | |
| 3. | 2,547,952 | $83,088,715 | 0.12% | |
| 4. | 1,065,303 | $34,739,531 | 0.06% | |
| 5. | 1,028,447 | $33,537,657 | 7.81% |
News See All
H.C. Wainwright Remains Bullish on Legend Biotech (LEGN), Cites Solid Growth Trajectory for CARVYKTI Therapy
Discussing the company’s robust growth trajectory for its CARVYKTI therapy, he pointed toward the therapy’s rising clinical potential.
15 Stocks Set to Explode in 2026
While the market figures out whether artificial intelligence is driving the next bubble or the next industrial revolution, a quiet rotation of capital into the next wave of growth leaders outside Big ...
J.P. Morgan Maintains a Buy on Legend Biotech Corporation (LEGN)
Legend Biotech Corporation (NASDAQ:LEGN) is one of the best healthcare stocks with the highest upside. J.P.
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
TD Cowen Reiterates a Buy Rating on Legend Biotech Corporation (LEGN)
Legend Biotech Corporation (NASDAQ:LEGN) is one of the best biotech stocks with high potential.
14 Biotech Stocks with High Potential
Healthcare was the second worst performer this year, with pharma and biotech companies under pressure.
RBC Capital Reiterates a Buy Rating on Legend Biotech Corporation (LEGN)
Legend Biotech Corporation (NASDAQ:LEGN) is one of the best strong buy stocks to invest in according to Wall Street.
12 Best Strong Buy Stocks to Invest in According to Wall Street
On September 26, Peter Boockvar, chief investment officer at One Point BFG Wealth Partners, appeared on CNBC to talk about the likelihood of the Federal Reserve’s interest rate cuts, new inflation data...
RBC Capital Lifts PT on Legend Biotech Corporation (LEGN) to $77 From $75
Legend Biotech Corporation (NASDAQ:LEGN) is one of the most promising future stocks according to Wall Street analysts.
Hedge Fund Resource Center Billionaire Hedge Funds
